Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Briel

Showing results (31-40 of 288) with videos related to

Pageof 29
Sort By:
Swiss Medical Weekly|November 30, 2017
Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholdersMatthias Briel, Bernice Elger, Erik von Elm, et al.
BMJ (Clinical Research Ed.)|April 1, 2010
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analysesXin Sun, Matthias Briel, Stephen D Walter, et al.
The American Journal of Medicine|October 7, 2004
Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trialsMatthias Briel, Marco Studer, Tracy R Glass, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|June 20, 2020
Working Through Ethics Review of Big Data Research Projects: An Investigation into the Experiences of Swiss and American ResearchersMaddalena Favaretto, Eva De Clercq, Matthias Briel, et al.
JAMA Network Open|November 30, 2021
Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical TrialsStuart McLennan, Barbara Nussbaumer-Streit, Lars G Hemkens, et al.
International Journal of Cardiology|March 17, 2012
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trialsRasha Khatib, Phillip Joseph, Matthias Briel, et al.
JAMA Network Open|October 27, 2021
Evaluation of Planned Subgroup Analysis in Protocols of Randomized Clinical TrialsAla Taji Heravi, Dmitry Gryaznov, Stefan Schandelmaier, et al.
Plos Medicine|June 8, 2018
Academic response to improving value and reducing waste: A comprehensive framework for INcreasing QUality In patient-oriented academic clinical REsearch (INQUIRE)Belinda von Niederhäusern, Gordon H Guyatt, Matthias Briel, et al.
Journal of Clinical Epidemiology|January 30, 2008
Early stopping of randomized clinical trials for overt efficacy is problematicDirk Bassler, Victor M Montori, Matthias Briel, et al.
Heart (British Cardiac Society)|February 25, 2016
Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?Alain Nordmann, Gregory Schwartz, Noah Vale, et al.
Pageof 29

Showing results (31-40 of 288) with videos related to

Sort By:
Pageof 29
Swiss Medical Weekly|November 30, 2017
Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholdersMatthias Briel, Bernice Elger, Erik von Elm, et al.
BMJ (Clinical Research Ed.)|April 1, 2010
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analysesXin Sun, Matthias Briel, Stephen D Walter, et al.
The American Journal of Medicine|October 7, 2004
Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trialsMatthias Briel, Marco Studer, Tracy R Glass, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|June 20, 2020
Working Through Ethics Review of Big Data Research Projects: An Investigation into the Experiences of Swiss and American ResearchersMaddalena Favaretto, Eva De Clercq, Matthias Briel, et al.
JAMA Network Open|November 30, 2021
Barriers and Facilitating Factors for Conducting Systematic Evidence Assessments in Academic Clinical TrialsStuart McLennan, Barbara Nussbaumer-Streit, Lars G Hemkens, et al.
International Journal of Cardiology|March 17, 2012
Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trialsRasha Khatib, Phillip Joseph, Matthias Briel, et al.
JAMA Network Open|October 27, 2021
Evaluation of Planned Subgroup Analysis in Protocols of Randomized Clinical TrialsAla Taji Heravi, Dmitry Gryaznov, Stefan Schandelmaier, et al.
Plos Medicine|June 8, 2018
Academic response to improving value and reducing waste: A comprehensive framework for INcreasing QUality In patient-oriented academic clinical REsearch (INQUIRE)Belinda von Niederhäusern, Gordon H Guyatt, Matthias Briel, et al.
Journal of Clinical Epidemiology|January 30, 2008
Early stopping of randomized clinical trials for overt efficacy is problematicDirk Bassler, Victor M Montori, Matthias Briel, et al.
Heart (British Cardiac Society)|February 25, 2016
Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?Alain Nordmann, Gregory Schwartz, Noah Vale, et al.
Pageof 29